Assisted Reproduction

Aspirin/Heparin Therapy Needs Further Study

Published in Women's Health Weekly, June 1st, 1998

Information on the first case of death associated with heparin and aspirin use among in vitro fertilization patients has been published by the U.S. Centers for Disease Control and Prevention (CDC).

Anticoagulation therapy, a combination of aspirin and heparin, is used routinely for women who have experienced several spontaneous abortions and have a specific auto-antibody profile. The therapy is being used more broadly to treat in vitro fertilization (IVF) patients although scientific evidence of its effectiveness is limited.

The CDC recently investigated the death of a pregnant woman who had undergone IVF and aspirin and heparin therapy. Although...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry